Journal List > J Korean Ophthalmol Soc > v.56(4) > 1010243

Ahn, Park, and Kim: Refractive Change after Transscleral Fixation of Intraocular Lens

초록

Purpose:

To evaluate the anterior chamber depth (ACD), extent of intraocular lens (IOL) tilt, and decentration and refractive error after transscleral fixation of IOL.

Methods:

We retrospectively reviewed the medical records of 17 cases with transscleral fixation of IOL (6 with aphakia, 5 with IOL dislocation, and 6 with lens subluxation). The acrylic IOL (MN60AC®) was fixated in 12 eyes and the polymethylmethacrylate IOL (CZ70BD®) was fixated in 5 eyes at 1.0 mm posterior from the limbus. We analyzed the ACD, extent of IOL tilt and decentration, manifest refraction, refractive error, higher order aberration, and corneal endothelium at 2 weeks, 1 month and 2 months postoperatively.

Results:

The mean ACD was 3.36 ± 0.11 mm, 3.30 ± 0.12 mm, and 3.27 ± 0.13 mm, the mean extent of IOL tilt was 4.61 ± 0.12°,4.65 ± 0.14°, and 4.60 ± 0.12° and the mean extent of IOL decentration was 0.43 ± 0.01 mm, 0.45 ± 0.01 mm, and 0.45 ± 0.01 mm at 2 weeks, 1 month and 2 months postoperatively, respectively in eyes with transscleral fixation of IOL. The ACD was shallower and the extent of IOL tilt and decentration was greater than with IOL in-the-bag insertion patients. The mean refractive errors were -0.55 ± 0.27 D, -0.63 ± 0.24 D, and -0.69 ± 0.19 D at the same period, respectively.

Conclusions:

Although postoperative refractive error is influenced by surgeon factors such as incision size, distance of fixation suture from limbus, and tightness of suture material, according to our results, an IOL 0.75 D more hyperopic than predicted should be selected in transscleral fixation of IOL at 1.0 mm posterior from the limbus. Additionally, each surgeon should assess their specific results and modify the lens calculations accordingly.

References

1. Hu BV, Shin DH, Gibbs KA, Hong YJ. Implantation of posterior chamber lens in the absence of capsular and zonular support. Arch Ophthalmol. 1988; 106:416–20.
crossref
2. Malbran ES, Malbran E Jr, Negri I. Lens guide suture for transport and fixation in secondary IOL implantation after intracapsular extraction. Int Ophthalmol. 1986; 9:151–60.
3. Stark WJ, Gottsch JD, Goodman DF, et al. Posterior chamber intraocular lens implantation in the absence of capsular support. Arch Ophthalmol. 1989; 107:1078–83.
crossref
4. Stark WJ, Goodman G, Goodman D, Gottsch J. Posterior chamber intraocular lens implantation in the absence of posterior capsular support. Ophthalmic Surg. 1988; 19:240–3.
crossref
5. Lee JH, Oh SY. Corneal endothelial cell loss from suture fixation of a posterior chamber intraocular lens. J Cataract Refract Surg. 1997; 23:1020–2.
crossref
6. Kjeka O, Bohnstedt J, Meberg K, Seland JH. Implantation of scler-al-fixated posterior chamber intraocular lenses in adults. Acta Ophthalmol. 2008; 86:537–42.
crossref
7. Chang JH, Lee JH. Long-term results of implantation of posterior chamber intraocular lens by suture fixation. Korean J Ophthalmol. 1991; 5:42–6.
crossref
8. Lewis JS. Ab externo sulcus fixation. Ophthalmic Surg. 1991; 22:692–5.
crossref
9. Lubniewski AJ, Holland EJ, Van Meter WS, et al. Histologic study of eyes with transsclerally sutured posterior chamber intraocular lenses. Am J Ophthalmol. 1990; 110:237–43.
crossref
10. Bellucci R, Pucci V, Morselli S, Bonomi L. Secondary implantation of angle-supported anterior chamber and scleral-fixated posterior chamber intraocular lenses. J Cataract Refract Surg. 1996; 22:247–52.
crossref
11. Steiner A, Steinhorst UH, Steiner M, et al. [Ultrasound biomicroscopy for localization of artificial lens haptics after transscleral suture fixation]. Ophthalmologe. 1997; 94:41–4.
12. Chang JH, Lee JH. Implantation of posterior chamber intraocular lenses by suture fixation without capsular and zonular support. Korean J Ophthalmol. 1989; 3:90–3.
crossref
13. Johnson SM. Results of exchanging anterior chamber lenses with sulcus-fixated posterior chamber IOLs without capsular support in penetrating keratoplasty. Ophthalmic Surg. 1989; 20:465–8.
crossref
14. Lee JH, Chang JH. Suture to limbus distances in eyes with a posterior chamber intraocular lens implanted by scleral fixation. J Cataract Refract Surg. 1993; 19:278–83.
crossref
15. Holladay JT. Evaluating the intraocular lens optic. Surv Ophthalmol. 1986; 30:385–90.
crossref
16. Engren AL, Behndig A. Anterior chamber depth, intraocular lens position, and refractive outcomes after cataract surgery. J Cataract Refract Surg. 2013; 39:572–7.
crossref
17. Sasaki K, Sakamoto Y, Shibata T, et al. Measurement of postoperative intraocular lens tilting and decentration using Scheimpflug images. J Cataract Refract Surg. 1989; 15:454–7.
crossref
18. Lee JG, Lee JH, Chung H. Factors contributing to retinal detachment after transscleral fixation of posterior chamber intraocular lenses. J Cataract Refract Surg. 1998; 24:697–702.
crossref
19. Krause L, Bechrakis NE, Heimann H, et al. Implantation of scleral fixated sutured posterior chamber lenses: a retrospective analysis of 119 cases. Int Ophthalmol. 2009; 29:207–12.
crossref
20. Heilskov T, Joondeph BC, Olsen KR, Blankenship GW. Late endophthalmitis after transscleral fixation of a posterior chamber intraocular lens. Arch Ophthalmol. 1989; 107:1427.
crossref
21. Teichmann KD, Teichmann IA. The torque and tilt gamble. J Cataract Refract Surg. 1997; 23:413–8.
crossref
22. Taskapili M, Gulkilik G, Engin G, et al. Transscleral fixation of a single-piece hydrophilic foldable acrylic intraocular lens. Can J Ophthalmol. 2007; 42:256–61.
crossref
23. Oshima Y, Oida H, Emi K. Transscleral fixation of acrylic intraocular lenses in the absence of capsular support through 3.5 mm self-sealing incisions. J Cataract Refract Surg. 1998; 24:1223–9.
crossref
24. Kohnen S, Ferrer A, Brauweiler P. Visual function in pseudophakic eyes with poly(methyl methacrylate), silicone, and acrylic intraocular lenses. J Cataract Refract Surg. 1996; 22(Suppl 2):1303–7.
crossref
25. Chan CK. An improved technique for management of dislocated posterior chamber implants. Ophthalmology. 1992; 99:51–7.
crossref
26. Fass ON, Herman WK. Sutured intraocular lens placement in aphakic post-vitrectomy eyes via small-incision surgery. J Cataract Refract Surg. 2009; 35:1492–7.
crossref
27. Duffey RJ, Holland EJ, Agapitos PJ, Lindstrom RL. Anatomic study of transsclerally sutured intraocular lens implantation. Am J Ophthalmol. 1989; 108:300–9.
crossref
28. Hayashi K, Hayashi H, Nakao F, Hayashi F. Intraocular lens tilt and decentration, anterior chamber depth, and refractive error after transscleral suture fixation surgery. Ophthalmology. 1999; 106:878–82.
29. Uozato H, Okada Y, Hirai H, Saishin M. What is the tolerable limits of the IOL tilt and decentration. Jpn Rev Clin Ophthalmol. 1988; 82:2308–11.
30. Uthoff D, Teichmann KD. Secondary implantation of scleral-fixated intraocular lenses. J Cataract Refract Surg. 1998; 24:945–50.
crossref
31. Bergren RL. Four-point fixation technique for sutured posterior chamber intraocular lenses. Arch Ophthalmol. 1994; 112:1485–7.
crossref
32. Almashad GY, Abdelrahman AM, Khattab HA, Samir A. Four-point scleral fixation of posterior chamber intraocular lenses without scleral flaps. Br J Ophthalmol. 2010; 94:693–5.
crossref
33. Berger RR, Kenyers AM, Van Coller B, Pretorius CF. Vertical tri-pod fixation (VTF) simplifies transscleral approaches. Ophthalmic Surg. 1995; 26:367–71.
crossref

Figure 1.
Scatterplot of correlation between the anterior chamber depth, IOL decentration, and IOL tilting with spherical equivalent (SE) error at postoperative 2 months in eyes with transscleral fixation of IOL. ACD = anterior chamber depth; IOL = intraocular lens.
jkos-56-548f1.tif
Table 1.
Etiologies of transscleral fixation of IOL in patients of group A
Etiology Number (%)
Aphakia 6 (35.29)
IOL dislocation 5 (29.41)
Lens subluxation  
  Trauma 3 (17.65)
  Spontaneous
3 (17.65)
Total 17

IOL = intraocular lens.

Table 2.
Preoperative clinical characteristics of each group
    Group A (n = 17) Group B (n = 39) p-value
Sex (M:F)   12:5 10:29 0.124
Age (years)   53.71 ± 3.80 63.26 ± 2.01 0.348
Laterality (right eye:left eye)   11:6 20:19 0.353
UCVA (log MAR)   1.01 ± 0.09 0.51 ± 0.03 <0.001*
BCVA (log MAR)   0.44 ± 0.06 0.38 ± 0.04 0.638
IOP (mm Hg)   16.71 ± 1.00 14.08 ± 0.48 0.021*
Axial length (mm)   24.65 ± 0.47 23.75 ± 0.20 0.061
ACD (mm)   3.15 ± 0.25 3.17 ± 0.07 0.922
Corneal endothelium Cell density (cells/mm2) 2,385.06 ± 163.70 2,665.46 ± 55.83 0.262
  Coefficient of variation 35.12 ± 1.52 34.13 ± 0.78 0.195
  Hexagonality 53.65 ± 2.62 53.77 ± 1.54 0.858
Keratometry (diopter)   1.47 ± 0.28 1.04 ± 0.10 0.260
Refraction (diopter) SE 1.23 ± 2.51 -0.14 ± 0.49 0.864
  Cylinder 1.30 ± 0.15 1.17 ± 0.17 0.121

Pearson's Chi-square test was used for numeric parameters; Mann Whitney U-test was used for continuous parameters; Values are presented as mean ± SD or number; Group A: transscleral fixation of IOL, Group B: phacoemulsification and in-the-bag insertion of IOL.

UCVA = uncorrected visual acuity; BCVA = best corrected visual acuity; IOP = intraocular pressure; ACD = anterior chamber depth; SE = spherical equivalent.

* Statistically significant differences ( p-value < 0.05) among groups.

Table 3.
Comparison of postoperative anterior chamber depth, extent of IOL tilt, and decentration
    Group A (n = 17) Group B (n = 39) p-value
ACD (mm) Preoperative 3.15 ± 0.25 3.17 ± 0.07 0.922
  POD #2 weeks 3.36 ± 0.11 4.14 ± 0.10 <0.001*
  POD #1 month 3.30 ± 0.12 4.19 ± 0.09 <0.001*
  POD #2 months 3.27 ± 0.13 4.23 ± 0.10 <0.001*
IOL tilt (°) POD #2 weeks 4.61 ± 0.12 1.24 ± 0.04 <0.001*
  POD #1 month 4.65 ± 0.14 1.37 ± 0.04 <0.001*
  POD #2 months 4.60 ± 0.12 1.30 ± 0.04 <0.001*
IOL decentration (mm) POD #2 weeks 0.43 ± 0.01 0.12 ± 0.01 <0.001*
  POD #1 month 0.45 ± 0.01 0.15 ± 0.01 <0.001*
  POD #2 months 0.45 ± 0.01 0.14 ± 0.01 <0.001*

Mann Whitney U-test was used; Values are presented as mean ± SD; Group A: transscleral fixation of IOL, Group B: phacoemulsification and in– the-bag insertion of IOL.

IOL = intraocular lens; ACD = anterior chamber depth; POD = postoperative day.

* Statistically significant differences ( p-value < 0.05) among groups;

Statistically significant differences ( p-value < 0.05) in Wilcoxon signed-rank test.

Table 4.
Comparison of postoperative refraction (mean spherical and mean cylinder) and spherical equivalent error of each group over time
    Group A (n = 17) Group B (n = 39) p-value
Mean spherical (diopter) Preoperative 1.90 ± 2.52 0.43 ± 0.51 0.872
POD #2 weeks -0.05 ± 0.12 -0.37 ± 0.13 0.079
POD #1 month -0.26 ± 0.20 -0.51 ± 0.13 0.380
POD #2 months -0.45 ± 0.18 -0.50 ± 0.15 0.957
Mean cylinder (diopter) Preoperative -1.30 ± 0.15 -1.17 ± 0.17 0.121
POD #2 weeks -2.34 ± 0.26 -0.83 ± 0.12 <0.001*
POD #1 month -1.93 ± 0.26 -0.84 ± 0.12 <0.001*
POD #2 months -1.63 ± 0.20 -0.90 ± 0.11 0.001*
Spherical equivalent error (diopter) POD #2 weeks -0.55 ± 0.27 -0.03 ± 0.08 0.022*
POD #1 month -0.63 ± 0.24 -0.17 ± 0.07 0.022*
POD #2 months -0.69 ± 0.19 -0.20 ± 0.08 0.018*
Astigmatism (algebraic value)(diopter) Preoperative -0.02 ± 0.37 -0.21 ± 0.26 0.867
POD #2 weeks 2.19 ± 0.33 -0.22 ± 0.18 <0.001*
POD #1 month 1.84 ± 0.29 -0.17 ± 0.18 <0.001*
POD #2 months 1.15 ± 0.35 -0.32 ± 0.17 0.001*

Mann Whitney U-test was used; Values are presented as mean ± SD; Group A: transscleral fixation of IOL, Group B: phacoemulsification and in-the-bag insertion of IOL.

POD = postoperative day.

* Statistically significant differences ( p-value < 0.05) among groups;

Statistically significant differences ( p-value < 0.05) in Wilcoxon signed-rank test.

Table 5.
Comparison of corneal astigmatism by Pentacam® of each group over time
    Group A (n = 17)
Group B (n = 39)
p-value
    WTR ATR WTR ATR
Keratometry (Pentacam®)(diopter) Preoperative 0.86 ± 0.16 1.15 ± 0.24 0.92 ± 0.14 1.08 ± 0.14 0.673/0.834
POD #2 weeks 2.01 ± 0.24 1.05 ± 0.15 1.02 ± 0.15 1.14 ± 0.15 0.002*/0.842
POD #1 month 1.63 ± 0.21 1.70 ± 0.61 0.91 ± 0.13 0.98 ± 0.12 0.010*/0.145
POD #2 months 1.37 ± 0.16 1.30 ± 0.43 1.01 ± 0.10 1.15 ± 0.16 0.067/0.763

Mann Whitney U-test was used; Values are presented as mean ± SD; Group A: transscleral fixation of IOL, Group B: phacoemulsification and in– the-bag insertion of IOL.

WTR = with-the-rule; ATR = against-the-rule; POD = postoperative day.

* Statistically significant differences ( p-value < 0.05) among groups;

Statistically significant differences ( p-value < 0.05) in Wilcoxon signed-rank test.

Table 6.
Comparison of postoperative outcomes by the type of IOL used in patients with transscleral fixation of IOL
    MN60AC® (n = 12) CZ70BD® (n = 5) p-value
BCVA (log MAR) Preoperative 0.46 ± 0.09 0.38 ± 0.08 0.914
POD #1 day 0.34 ± 0.08 0.40 ± 0.09 0.558
POD #2 weeks 0.24 ± 0.06 0.28 ± 0.02 0.484
POD #1 month 0.20 ± 0.04 0.26 ± 0.02 0.381
POD #2 months 0.18 ± 0.04 0.22 ± 0.06 0.662
ACD (mm) Preoperative 2.83 ± 0.29 3.35 ± 0.78 0.692
POD #2 weeks 3.77 ± 0.10 3.12 ± 0.34 0.077
POD #1 month 3.68 ± 0.11 2.98 ± 0.33 0.077
POD #2 months 3.86 ± 0.21 3.00 ± 0.32 0.077
IOL tilting (°) POD #2 weeks 5.27 ± 0.17 5.24 ± 0.23 0.811
POD #1 month 5.32 ± 0.17 5.37 ± 0.15 1
POD #2 months 5.33 ± 0.17 5.38 ± 0.14 1
IOL decentration (mm) POD #2 weeks 0.56 ± 0.01 0.57 ± 0.01 0.469
POD #1 month 0.56 ± 0.01 0.57 ± 0.01 0.371
POD #2 months 0.56 ± 0.01 0.57 ± 0.01 0.469
Mean cylinder (diopter) Preoperative -1.30 ± 0.11 -1.50 ± 0.25 0.389
POD #2 weeks -2.45 ± 0.27 -3.33 ± 0.60 0.149
POD #1 month -1.83 ± 0.33 -2.83 ± 0.79 0.167
POD #2 months -1.35 ± 0.25 -2.25 ± 0.50 0.058
Astigmatism (algebraic value) (diopter) Preoperative -0.10 ± 0.45 -0.33 ± 1.06 1
POD #2 weeks 2.20 ± 0.45 3.33 ± 0.60 0.149
POD #1 month 1.68 ± 0.41 2.83 ± 0.79 0.167
POD #2 months 0.53 ± 0.48 2.25 ± 0.50 0.061

Mann Whitney U-test was used; Values are presented as mean ± SD.

BCVA = best corrected visual acuity; ACD = anterior chamber depth; IOL = intraocular lens; POD = postoperative day.

TOOLS
Similar articles